Testing for congenital disorders of glycosylation by HPLC measurement of serum transferrin glycoforms

Clinical Chemistry

Volumn 50, Issue 5, 2004, Pages 954-958

  Helander, Anders ^a,c   Bergström, Jonas ^a   Freeze, Hudson H ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b BURNHAM INSTITUTE   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN; TRANSFERRIN;

AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONGENITAL DISORDER OF GLYCOSYLATION; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRECIPITATION; PROTEIN ANALYSIS; REPRODUCIBILITY; SEX DIFFERENCE; SUPERNATANT; TRANSFERRIN BLOOD LEVEL;

ADOLESCENT; ADULT; ALCOHOL DRINKING; CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GLYCOSYLATION; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; TRANSFERRIN;

EID: 2142759526     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.029629     Document Type: Article

References (21)

1. Jaeken J. Komrower Lecture. Congenital disorders of glycosylation (CDG): it's all in it! J Inherit Metab Dis 2003;26:99-118.
2. Marquardt T, Denecke J. Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies. Eur J Pediatr 2003;162:359-79.
3. Thiel C, Schwarz M, Peng J, Grzmil M, Hasilik M, Braulke T, et al. A new type of congenital disorders of glycosylation (CDG-II) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis. J Biol Chem 2003;278:22498-505.
4. Wu X, Rush JS, Karaoglu D, Krasnewich D, Lubinsky MS, Waechter CJ, et al. Deficiency of UDP-GlcNAc:dolichol phosphate N-acetylglucosamine-1 phosphate transferase (DPAGT1) causes a novel congenital disorder of glycoation type Ij. Hum Mutat 2003;22:144-50.
5. Schwarz M, Thiel C, Lubbehusen J, Dorland B, De Koning T, Von Figura K, et al. Deficiency of GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase causes congenital disorder of glycosylation type Ik. Am J Hum Genet 2004;74:472-81.
6. Freeze HH. Congenital disorders of glycosylation and the pediatric liver. Semin Liver Dis 2001;21:501-15.
7. Briones P, Vilaseca MA, Garcia-Silva MT, Pineda M, Colomer J, Ferrer I, et al. Corgenital disorders of giycosylation (CDG) may be underdiagnosed when mimicking mitochondrial disease. Eur J Paediatr Neurol 2001;5:127-31.
8. Enns GM, Steiner RD, Buist N, Cowan C, Leppig KA, McCracken MF, et al. Clinical and molecular features of congenital disorder of glycosylation in patients with type 1 sialotransferrin pattern and diverse ethnic origins. J Pediatr 2002;141:695-700.
9. Lacey JM, Bergen HR, Magera MJ, Naylor S, O'Brien JF. Rapid Determination of transferrin isoforms by immunoaffinity liquid chromatography and electrospray mass spectrometry. Clin Chem 2001;47:513-B.
10. Callewaert N, Schollen E, Vanhecke A, Jaeken J, Matthijs G, Contreras R. Increased fucosylation and reduced branching of serum glycoprotein N-glycans in all known subtypes of congenital disorder of glycosylation I. Glycobiology 2003;13:367-75.
11. Jaeken J, Schachter H, Carchon H, De Cock P, Coddeville B, Spik G. Carbohydrate deficient glycoprotein syndrome type II: a deficiency in Golgi localised N-acetyl-glucosaminyltransferase II. Arch Dis Child 1994;71: 123-7.
12. Hansske B, Thiel C, Lubke T, Hasilik M, Honing S, Peters V, et al. Deficiency of UDP-galactose:N-acetylglucasamine β-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId. J Clin Invest 2002;109: 725-33.
13. Peters V, Penzien JM, Reiter G, Korner C, Hackler R, Assmann B, et al. Congenital disorder of glycosylation IId (CDG-IId) - a new entity: clinical presentation with Dandy-Walker malformation and myopathy. Neuropediatrics 2002;33:27-32.
14. Helander A, Husa A, Jeppsson J-O. Improved HPLC method for carbohydrate-deficient transferrin in serum. Clin Chem 2003;49:1881-90.
15. Westphal V, Kjaergaard S, Davis JA, Peterson SM, Skovby F, Freeze HH. Genetic and metabolic analysis of the first adult with congenital disorder of glycosylation type Ib: long-term outcome and effects of mannose supplementation. Mol Genet Metab 2001;73:77-85.
16. Helander A, Eriksson G. Stibler H, Jeppsson J-O. Interference of transferrin isoform types with carbohydrate-deficient transferrin quantification in the identification of alcohol abuse. Clin Chem 2001;47:1225-33.
17. Coddeville B, Carchon H, Jaeken J, Briand G, Spik G. Determination of glycan structures and molecular masses of the glycovariants of serum transferrin from a patient with carbohydrate deficient syndrome type II. Glycoconj J 1998;15:265-73.
18. Mills PB, Mills K, Mian N, Winchester BG, Clayton PT. Mass spectrometric analysis of glycans in elucidating the pathogenesis of CDG type IIx. J Inherit Metab Dis 2003;26:119-34.
19. Henry H, Froehlich F, Perret R, Tissot JD, Eilers-Messerli B, Lavanchy D, et al. Microheterogeneity of serum glycoproteins in patients with chronic alcohol abuse compared with carbohydrate-deficient glycoprotein syndrome type I. Clin Chem 1999;45:1408-13.
20. Legros FJ, Nuyens V, Minet E, Emonts P, Boudjeltia KZ, Courbe A, et al. Carbohydrate-deficient transferrin isoforms measured by capillary zone electrophoresis for detection of alcohol abuse. Clin Chem 2002;48:2177-86.
21. Carchon HA, Chevigne R, Falmagne JB, Jaeken J. Diagnosis of congenital disorders of glycosylation by capillary zone electrophoresis of serum transferrin. Clin Chem 2004;50:101-11.